Australasian Recurrent Pregnancy Loss Clinical Management Guideline 2024 Part I.
RPL
guideline
recurrent miscarriage
recurrent pregnancy loss
Journal
The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027
Informations de publication
Date de publication:
27 Jun 2024
27 Jun 2024
Historique:
received:
21
09
2023
accepted:
03
04
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
27
6
2024
Statut:
aheadofprint
Résumé
Guidelines for the investigation and management of recurrent pregnancy loss (RPL) have been developed in Europe, USA and UK, but there is currently no Australasian guideline. The Australasian Certificate of Reproductive Endocrinology and Infertility Consensus Expert Panel on Trial Evidence group has prepared a two-part guideline to provide guidance on the management of RPL. In Part I chromosomal, anatomical, and endocrine factors are outlined along with relevant recommendations for clinical management, levels of evidence and grades of consensus. In Part II thrombophilia, autoimmune factors, infective, inflammatory, and endometrial causes, environmental and lifestyle factors, male factor and unexplained causes will be outlined.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Investigateurs
Rob Norman
(R)
Gab Kovacs
(G)
Lucy Prentice
(L)
Elizabeth Glanville
(E)
Leigh Searle
(L)
Olivia Stuart
(O)
Vicki Nisenblat
(V)
Neil Johnson
(N)
Yousif Alyousif
(Y)
Maree Lee
(M)
Kate Burston
(K)
Michael Chapman
(M)
Phill McChessney
(P)
Clare Boothroyd
(C)
Neerja Kamal
(N)
Anne Clark
(A)
Violet Kieu
(V)
Rituparna Dutta
(R)
Lynn Burmeister
(L)
Ashleigh Smith
(A)
Louise Hull
(L)
Vamsee Thalluri
(V)
Giselle Crawford
(G)
Beverley Vollenhoven
(B)
Sarah Hunt
(S)
Nicole Hope
(N)
Sameer Jakar
(S)
Jinny Foo
(J)
Iris Wang
(I)
Rabia Shaik
(R)
Seema Mohiuddin
(S)
Fleur Cattrall
(F)
Peter Leung
(P)
Roger Hart
(R)
Alison Gee
(A)
Katrina Rowan
(K)
Michele Kwik
(M)
Tamara Hunter
(T)
Nalini Gayer
(N)
Raelia Lew
(R)
Rebecca Mackenzie-Proctor
(R)
Anusch Yazdani
(A)
Rob Lahoud
(R)
Cheryl Phua
(C)
Shannon Zawada
(S)
Gabrielle Dezarnaulds
(G)
Sonal Karia
(S)
Devini Ameratunga
(D)
Vanessa Ross
(V)
Manny Mangat
(M)
Raewyn Tierney
(R)
Shadi Khashaba
(S)
David Greening
(D)
Janelle McDonald
(J)
Myvanwy McAveen
(M)
Danielle Robson
(D)
Informations de copyright
© 2024 The Author(s). Australian and New Zealand Journal of Obstetrics and Gynaecology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Références
Royal College of Obstetricians & Gynaecologists (RCOG). The Investigation and Treatment of Couples with Recurrent First Trimester and Second Trimester Miscarriage, Green‐top guideline no. 17. 2011 [Accessed 20 June 2023]. Available from URL: https://ranzcog.edu.au/wp‐content/uploads/2022/05/The‐Investigation‐and‐Treatment‐of‐Couples‐with‐Recurrent‐First‐trimester‐and‐Second‐trimester‐Miscarriage.pdf.
Little AB. There's many a slip 'twixt implantation and the crib. N Engl J Med 1988; 319(4): 241–242.
Stirrat GM. Recurrent miscarriage. Lancet 1990; 336(8716): 673–675.
Practice Committee of the American Society for Reproductive M. Evaluation and treatment of recurrent pregnancy loss: A committee opinion. Fertil Steril 2012; 98(5): 1103–1111.
European Society of Human Reproduction & Embryology (ESHRE). Guideline on the management of recurrent pregnancy loss. 2022 [Accessed 20 June 2023]. Available from URL: https://www.eshre.eu/Guidelines‐and‐Legal/Guidelines/Recurrent‐pregnancy‐loss.
van Dijk MM, Kolte AM, Limpens J et al. Recurrent pregnancy loss: Diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta‐analysis. Hum Reprod Update 2020; 26(3): 356–367.
Shekelle PG, Maglione MA, Luoto J. Global Health Evidence Evaluation Framework. Rockville (MD): Agency for Healthcare Research and Quality (US), 2013; Table B.9, NHMRC Evidence Hierarchy: designations of ‘levels of evidence’ according to type of research question (including explanatory notes) [Accessed 22 June 2023]. Available from URL: https://www.ncbi.nlm.nih.gov/books/NBK121300/table/appb.t21/.
Philipp T, Philipp K, Reiner A et al. Embryoscopic and cytogenetic analysis of 233 missed abortions: Factors involved in the pathogenesis of developmental defects of early failed pregnancies. Hum Reprod 2003; 18(8): 1724–1732.
Sugiura‐Ogasawara M, Ozaki Y, Katano K et al. Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum Reprod 2012; 27(8): 2297–2303.
Tur‐Torres MH, Garrido‐Gimenez C, Alijotas‐Reig J. Genetics of recurrent miscarriage and fetal loss. Best Pract Res Clin Obstet Gynaecol 2017; 42: 11–25.
Carp H, Feldman B, Oelsner G, Schiff E. Parental karyotype and subsequent live births in recurrent miscarriage. Fertil Steril 2004; 81(5): 1296–1301.
Popescu F, Jaslow CR, Kutteh WH. Recurrent pregnancy loss evaluation combined with 24‐chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients. Hum Reprod 2018; 33(4): 579–587.
Franasiak JM, Forman EJ, Hong KH et al. The nature of aneuploidy with increasing age of the female partner: A review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril 2014; 101(3): 656–663.e1.
Sugiura‐Ogasawara M, Ozaki Y, Sato T et al. Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocations. Fertil Steril 2004; 81(2): 367–373.
Kabessa M, Harlev A, Friger M et al. Pregnancy outcomes among patients with recurrent pregnancy loss and chromosomal aberration (CA) without PGD. J Perinat Med 2018; 46(7): 764–770.
Franssen MT, Korevaar JC, Leschot NJ et al. Selective chromosome analysis in couples with two or more miscarriages: Case‐control study. BMJ 2005; 331(7509): 137–141.
Gardner M, Sutherland G, Shaffer L. Chromosome Abnormalities and Genetic Counselling, 4th edn. Oxford, UK: Oxford University Press, 2012.
Chow JFC, Yeung WSB, Lee VCY et al. Evaluation of preimplantation genetic testing for chromosomal structural rearrangement by a commonly used next generation sequencing workflow. Eur J Obstet Gynecol Reprod Biol 2018; 224: 66–73.
Christodoulou C, Dheedene A, Heindryckx B et al. Preimplantation genetic diagnosis for chromosomal rearrangements with the use of array comparative genomic hybridization at the blastocyst stage. Fertil Steril 2017; 107(1): 212–219.e3.
Idowu D, Merrion K, Wemmer N et al. Pregnancy outcomes following 24‐chromosome preimplantation genetic diagnosis in couples with balanced reciprocal or Robertsonian translocations. Fertil Steril 2015; 103(4): 1037–1042.
Li G, Jin H, Xin Z et al. Increased IVF pregnancy rates after microarray preimplantation genetic diagnosis due to parental translocations. Syst Biol Reprod Med 2014; 60(2): 119–124.
Murugappan G, Shahine LK, Perfetto CO et al. Intent to treat analysis of in vitro fertilization and preimplantation genetic screening versus expectant management in patients with recurrent pregnancy loss. Hum Reprod 2016; 31(8): 1668–1674.
Harger JH, Archer DF. Etiology of recurrent pregnancy losses and outcomes of subsequent pregnancies. Obstet Gynecol 1983; 62(5): 574–581.
Acien PAM, Sanchez‐Ferrer M. Complex malformations of the femal genital tract. New types and revision of classification. Hum Reprod 2004; 19(10): 2377–2384.
Grimbizis GF, Camus M, Tarlatzis BC et al. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 2001; 7(2): 161–174.
Devi Wold AS, Pham N, Arici A. Anatomic factgors in recurrent pregnancy loss. Semin Reprod Med 2006; 24(1): 25–32.
Bosteels J, van Wessel S, Weyers S et al. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev 2018; 12(12): CD009461.
Salim S, Won H, Nesbitt‐Hawes E et al. Diagnosis and management of endometrial polyps: A critical review of the literature. J Minim Invasive Gynecol 2011; 18(5): 569–581.
Elsokkary M, Elshourbagy M, Labib K et al. Assessment of hysteroscopic role in management of women with recurrent pregnancy loss. J Matern Fetal Neonatal Med 2018; 31(11): 1494–1504.
Seckin B, Sarikaya E, Oruc AS et al. Office hysteroscopic findings in patients with two, three, and four or more, consecutive miscarriages. Eur J Contracept Reprod Health Care 2012; 17(5): 393–398.
Perez‐Medina T, Bajo‐Arenas J, Salazar F et al. Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: A prospective, randomized study. Hum Reprod 2005; 20(6): 1632–1635.
Kroon B, Johnson N, Chapman M et al. Fibroids in infertility—consensus statement from ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence). Aust N Z J Obstet Gynaecol 2011; 51(4): 289–295.
Simpson JL. Causes of fetal wastage. Clin Obstet Gynecol 2007; 50(1): 10–30.
Deans R, Abbott J. Review of intrauterine adhesions. J Minim Invasive Gynecol 2010; 17(5): 555–569.
Hooker AB, Lemmers M, Thurkow AL et al. Systematic review and meta‐analysis of intrauterine adhesions after miscarriage: Prevalence, risk factors and long‐term reproductive outcome. Hum Reprod Update 2014; 20(2): 262–278.
Rikken JFW, Kowalik CR, Emanuel MH et al. The randomised uterine septum transsection trial (TRUST): Design and protocol. BMC Womens Health 2018; 18(1): 163.
Budden A, Abbott JA. The diagnosis and surgical approach of uterine septa. J Minim Invasive Gynecol 2018; 25(2): 209–217.
Homer HA, Li TC, Cooke ID. The septate uterus: A review of management and reproductive outcome. Fertil Steril 2000; 73(1): 1–14.
Acien P, Acien M. The presentation and management of complex female genital malformations. Hum Reprod Update 2016; 22(1): 48–69.
Bhagavath B, Ellie G, Griffiths KM et al. Uterine malformations: An update of diagnosis, management, and outcomes. Obstet Gynecol Surv 2017; 72(6): 377–392.
Hur C, Rehmer J, Flyckt R, Falcone T. Uterine factor infertility: A clinical review. Clin Obstet Gynecol 2019; 62(2): 257–270.
Nouri K, Ott J, Huber JC et al. Reproductive outcome after hysteroscopic septoplasty in patients with septate uterus – a retrospective cohort study and systematic review of the literature. Reprod Biol Endocrinol 2010; 8: 52.
Bailey AP, Jaslow CR, Kutteh WH. Minimally invasive surgical options for congenital and acquired uterine factors associated with recurrent pregnancy loss. Womens Health (Lond) 2015; 11(2): 161–167.
Pabuccu R, Atay V, Orhon E et al. Hysteroscopic treatment of intrauterine adhesions is safe and effective in the restoration of normal menstruation and fertility. Fertil Steril 1997; 68(6): 1141–1143.
Yu D, Li TC, Xia E et al. Factors affecting reproductive outcome of hysteroscopic adhesiolysis for Asherman's syndrome. Fertil Steril 2008; 89(3): 715–722. https://pubmed.ncbi.nlm.nih.gov/17681324.
Krog MC, Nielsen HS, Christiansen OB, Kolte AM. Reproductive endocrinology in recurrent pregnancy loss. Clin Obstet Gynecol 2016; 59(3): 474–486.
Alexander EK, Pearce EN, Brent GA et al. 2017 guidelines of the American Thyroid Association for the diagnosis and Management of Thyroid Disease during Pregnancy and the postpartum. Thyroid 2017; 27(3): 315–389.
Hamblin PS, Sheehan PM, Allan C et al. Subclinical hypothyroidism during pregnancy: The Melbourne public hospitals consensus. Intern Med J 2019; 49(8): 994–1000.
Stagnaro‐Green A, Pearce E. Thyroid disorders in pregnancy. Nat Rev Endocrinol 2012; 8(11): 650–658.
Stagnaro‐Green A. Thyroid antibodies and miscarriage: Where are we at a generation later? J Thyroid Res 2011; 2011: 841949.
Negro R, Schwartz A, Gismondi R et al. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 2010; 95(9): E44–E48.
Negro R, Mestman JH. Thyroid disease in pregnancy. Best Pract Res Clin Endocrinol Metab 2011; 25(6): 927–943.
Bernardi LA, Cohen RN, Stephenson MD. Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss. Fertil Steril 2013; 100(5): 1326–1331.
Lazarus JH. Thyroid function in pregnancy. Br Med Bull 2011; 97: 137–148.
Negro R, Stagnaro‐Green A. Clinical aspects of hyperthyroidism, hypothyroidism, and thyroid screening in pregnancy. Endocr Pract 2014; 20(6): 597–607.
Akhtar MA, Agrawal R, Brown J et al. Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism. Cochrane Database Syst Rev 2019; 6(6): CD011009.
Thangaratinam S, Tan A, Knox E et al. Association between thyroid autoantibodies and miscarriage and preterm birth: Meta‐analysis of evidence. BMJ 2011; 342: d2616.
De Groot L, Abalovich M, Alexander EK et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97(8): 2543–2565.
Vissenberg R, van den Boogaard E, van Wely M et al. Treatment of thyroid disorders before conception and in early pregnancy: A systematic review. Hum Reprod Update 2012; 18(4): 360–373.
Dizon‐Townson DMC, Sibai B, Spong CY et al. The relationship between the factor V leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005; 106(3): 517–524.
Rao M, Zeng Z, Zhou F et al. Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: A systematic review and meta‐analysis. Hum Reprod Update 2019; 25(3): 344–361.
Wang H, Gao H, Chi H et al. Effect of levothyroxine on miscarriage among women with Normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer: A randomized clinical trial. JAMA 2017; 318(22): 2190–2198.
Bussen S, Sutterlin M, Steck T. Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion. Hum Reprod 1999; 14(1): 18–20.
Li W, Ma N, Laird SM et al. The relationship between serum prolactin concentration and pregnancy outcome in women with unexplained recurrent miscarriage. J Obstet Gynaecol 2013; 33(3): 285–288.
Hirahara F, Andoh N, Sawai K et al. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril 1998; 70(2): 246–252.
Teede HJ, Misso ML, Costello MF et al. Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; 110(3): 364–379.
Homburg R. Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metab 2006; 20(2): 281–292.
Wang JX, Davies MJ, Norman RJ. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 2001; 16(12): 2606–2609.
Craig LB, Ke RW, Kutteh WH. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril 2002; 78(3): 487–490.
Wani AA, Gul I, Jabeen F et al. Relationship of insulin resistance with recurrent pregnancy loss. Int J Reprod Contracept Obstet Gynecol 2017; 6(4): 1312.
Zolghadri J, Tavana Z, Kazerooni T et al. Relationship between abnormal glucose tolerance test and history of previous recurrent miscarriages, and beneficial effect of metformin in these patients: A prospective clinical study. Fertil Steril 2008; 90(3): 727–730.
Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990; 336(8724): 1141–1144.
Best D, Avenell A, Bhattacharya S. How effective are weight‐loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta‐analysis of the evidence. Hum Reprod Update 2017; 23(6): 681–705.
Clark AM, Ledger W, Galletly C et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995; 10(10): 2705–2712.
Glueck CJ, Phillips H, Cameron D et al. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first‐trimester spontaneous abortion: A pilot study. Fertil Steril 2001; 75(1): 46–52.
Nawaz FH, Khalid R, Naru T, Rizvi J. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome? J Obstet Gynaecol Res 2008; 34(5): 832–837.
Boots CE, Bernardi LA, Stephenson MD. Frequency of euploid miscarriage is increased in obese women with recurrent early pregnancy loss. Fertil Steril 2014; 102(2): 455–459.
Broughton DE, Moley KH. Obesity and female infertility: Potential mediators of obesity's impact. Fertil Steril 2017; 107(4): 840–847.
Cavalcante MB, Sarno M, Peixoto AB et al. Obesity and recurrent miscarriage: A systematic review and meta‐analysis. J Obstet Gynaecol Res 2019; 45(1): 30–38.
Clark AM, Thornley B, Tomlinson L et al. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 1998; 13(6): 1502–1505.
Einarsson S, Bergh C, Friberg B et al. Weight reduction intervention for obese infertile women prior to IVF: A randomized controlled trial. Hum Reprod 2017; 32(8): 1621–1630.
Ispasoiu CA, Chicea R, Stamatian FV, Ispasoiu F. High fasting insulin levels and insulin resistance may be linked to idiopathic recurrent pregnancy loss: A case‐control study. Int J Endocrinol 2013; 2013: 576926.
Matjila MJ, Hoffman A, van der Spuy ZM. Medical conditions associated with recurrent miscarriage‐is BMI the tip of the iceberg? Eur J Obstet Gynecol Reprod Biol 2017; 214: 91–96.
Romero ST, Sharshiner R, Stoddard GJ et al. Correlation of serum fructosamine and recurrent pregnancy loss: Case‐control study. J Obstet Gynaecol Res 2016; 42(7): 763–768.
Wang Y, Zhao H, Li Y et al. Relationship between recurrent miscarriage and insulin resistance. Gynecol Obstet Investig 2011; 72(4): 245–251.
Haas DM, Hathaway TJ, Ramsey PS. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database Syst Rev 2019; 2019(11): CD003511.
Coomarasamy A, Devall AJ, Cheed V et al. A randomized trial of progesterone in women with bleeding in early pregnancy. N Engl J Med 2019; 380(19): 1815–1824.
Hong Li Y, Marren A. Recurrent pregnancy loss: A summary of international evidence‐based guidelines and practice. Aust J Gen Pract 2018; 47(7): 432–436.
Reichman D, Laufer MR, Robinson BK. Pregnancy outcomes in unicornuate uteri: A review. Fertil Steril 2009; 91(5): 1886–1894.
Fedele L, Zamberletti D, Vercellini P et al. Reproductive performance of women with unicornuate uterus. Fertil Steril 1987; 47(3): 416–419.
Golan A, Langer R, Bukovsky I, Caspi E. Congenital anomalies of the mullerian system. Fertil Steril 1989; 51(5): 747–755.
Green LK, Harris RE. Uterine anomalies. Frequency of diagnosis and associated obstetric complications. Obstet Gynecol 1976; 47(4): 427–429.
Heinonen PK, Saarikoski S, Pystynen P. Reproductive performance of women with uterine anomalies. An evaluation of 182 cases. Acta Obstet Gynecol Scand 1982; 61(2): 157–162.
Proctor JA, Haney AF. Recurrent first trimester pregnancy loss is associated with uterine septum but not with bicornuate uterus. Fertil Steril 2003; 80(5): 1212–1215.
Chan YY, Jayaprakasan K, Tan A et al. Reproductive outcomes in women with congenital uterine anomalies: A systematic review. Ultrasound Obstet Gynecol 2011; 38(4): 371–382.
Acien P. Incidence of Mullerian defects in fertile and infertile women. Hum Reprod 1997; 12(7): 1372–1376.